Sucy en Brie, France

Gerard Ponsinet

This inventor holds 29 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Rhone-Poulenc Industries, Rhone-Poulenc Sante, Rhone-Poulenc S.a.. Active years: 1976-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 66(Granted Patents)


Location History:

  • Sceaux, FR (1976 - 1978)
  • Sucy-En-Brie, FR (1977 - 1991)

Company Filing History:


Years Active: 1976-1991

Loading Chart...
Areas of Expertise:
Isoindolinone Derivatives
Alkadiene Derivatives
Neuroleptics
Pyrrolo Derivatives
Thiazolo Compounds
Antiviral Compositions
Daunorubicin Derivatives
Isoquinoline Derivatives
Thiazoline Derivatives
Dithiocarbamates
Indole Derivatives
Antibiotic Compounds
29 patents (USPTO):Explore Patents

Title: Inventor Gerard Ponsinet

Introduction: Gerard Ponsinet is a renowned inventor hailing from Sucy-en-Brie, France. He has made significant contributions to the field of innovations and patents.

Latest Patents: Gerard Ponsinet holds several patents in various industries, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his career, Gerard Ponsinet has been recognized for his groundbreaking inventions that have had a lasting impact on the technological landscape. His innovative spirit and dedication to pushing boundaries have set him apart in the world of inventors.

Collaborations: Gerard Ponsinet has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work with multidisciplinary teams has led to the successful development and commercialization of his patented technologies.

Conclusion: In conclusion, Gerard Ponsinet's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the global community. His contributions continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…